Tag: Sandoz
Biosimilar biotech company achieves first approval success
Frankfurt It is not every day that German biotech companies receive product approvals for their new drug developments. The Munich Formycon has now achieved such a success both in the…
Novartis wants to spin off its generics division and take it public
Novartis The Swiss pharmaceutical company is likely to focus on high-margin new drugs in the future. (Photo: Reuters) Zurich The Swiss pharmaceutical company Novartis wants to spin off its business…
Novartis wants to spin off its generics division and take it public
Novartis The Swiss pharmaceutical company is likely to focus on high-margin new drugs in the future. (Photo: Reuters) Zurich The Swiss pharmaceutical company Novartis wants to spin off its business…
Fever juice for children is running out
Frankfurt Fever and pain-relieving juices for children are hard to come by in many pharmacies. While liquid preparations with the active ingredient paracetamol were initially affected, juices with the active…
Fever juice for children is running out
Frankfurt Fever and pain-relieving juices for children are hard to come by in many pharmacies. While liquid preparations with the active ingredient paracetamol were initially affected, juices with the active…
Big Pharma is boosting the blockbuster business with spin-offs
Frankfurt The pharmaceutical industry is in the middle of a profound structural change. The leading companies in the industry are increasingly specializing in drug production. And part with fringe activities…
“Acquisitions are always an option”
Production at Fresenius Kabi The business of the drug division of the group is expected to grow significantly. (Photo: Fresenius) Frankfurt The healthcare group Fresenius intends to play a key…
Pause recommended for 100 generics
medication Approval for around 100 generics in Europe is to be suspended because a contract institute in India has worked poorly in the studies relevant to the approval of the…
Novartis reorganizes itself and fires three top managers
Novartis boss Vasant Narasimhan (Photo: imago images/IP3press) Zurich The Swiss pharmaceutical company Novartis is realigning its core business. In the business with patent-protected drugs – called Innovative Medicines – the…
Swiss equities as a safe haven in times of crisis
Production at Nestlé, Roche, Novartis and Givaudan Swiss stocks from the pharmaceutical and food sectors are considered crisis-resistant. (Photo: AFP/Getty Images) Frankfurt. The Swiss financial market has the reputation of…
Clariant postpones closing due to possible incorrect postings
Clariant headquarters in Pratteln The chemical company is investigating whether employees have posted the provisions and accruals incorrectly in order to steer the company’s results in such a way that…
Pfizer is again the number one in the pharmaceutical industry
vaccine production Comirnaty alone delivered $36.8 billion last year, the highest annual sales for any single pharmaceutical product. (Photo: AP) Frankfort, New York After a one-year hiatus, the US pharmaceutical…
Pfizer is again the number one in the pharmaceutical industry
vaccine production Comirnaty alone delivered $36.8 billion last year, the highest annual sales for any single pharmaceutical product. (Photo: AP) Frankfort, New York After a one-year hiatus, the US pharmaceutical…
Reliable dividends & consistently high profits
dividend yield Dividends are far more stable than corporate earnings and stock prices. (Photo: Stephan Schmitz) Dusseldorf The idea sounds great: buy stocks with high dividends and low prices. This…
Reliable dividends & consistently high profits
dividend yield Dividends are far more stable than corporate earnings and stock prices. (Photo: Stephan Schmitz) Dusseldorf The idea sounds great: buy stocks with high dividends and low prices. This…
Pharmaceutical industry is realigning itself
Rather, the change is marked by larger spin-offs – and the strategy of the big pharmaceutical companies to concentrate more on the innovative pharmaceutical business. According to experts, these plans…
Pharmaceutical industry is realigning itself
Rather, the change is marked by larger spin-offs – and the strategy of the big pharmaceutical companies to concentrate more on the innovative pharmaceutical business. According to experts, these plans…
CSL plans to buy pharmaceutical company Vifor for $ 12 billion
Vifor logo The Swiss pharmaceutical company could pass into Australian ownership. (Photo: Reuters) Zurich The Swiss pharmaceutical company Vifor confirmed takeover negotiations with the Australian pharmaceutical company CSL on Monday.…
CSL plans to buy pharmaceutical company Vifor for $ 12 billion
Vifor logo The Swiss pharmaceutical company could pass into Australian ownership. (Photo: Reuters) Zurich The Swiss pharmaceutical company Vifor confirmed takeover negotiations with the Australian pharmaceutical company CSL on Monday.…
Major shareholders are considering billion-dollar deal with financial investor
Sandoz Novartis announced in October that it would initiate a strategic review of its generics business, Sandoz. Photo: Sandoz Frankfurt According to circles, the Strüngmann family behind the Covid vaccine…